Aller au contenu principal
Accès ouvert déclaré 2026 article

Perioperative anesthetic management in pediatric patients with medically refractory pulmonary arterial hypertension undergoing surgical or transcatheter potts shunt: a retrospective case series

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Pulmonary arterial hypertension (PAH), a life-threatening disorder in children, necessitates palliative interventions like Potts shunt (surgical/transcatheter) for medically refractory cases. Perioperative anesthesia management remains challenging due to hemodynamic instability. This study describes our institutional anesthetic approach and summarizes the perioperative outcomes of 28 pediatric patients who underwent Potts shunt creation. METHODS: A retrospective analysis was conducted on 28 consecutive children who underwent either surgical or transcatheter Potts shunt at Shanghai Children's Medical Center between 2021 and 2024. Perioperative data were extracted from structured electronic medical records. RESULTS: Among the 28 patients, 18 underwent surgical Potts shunt creation (100% requiring cardiopulmonary bypass [CPB], median CPB duration: 91[82-108] minutes) and 10 underwent transcatheter procedures (20% requiring CPB). Anesthesia induction predominantly utilized ciprofol-alfentanil (60.7%) and s-ketamine (28.6%). Preoperative treprostinil was universal, with 7.1% of patients requiring additional vasoactive agents. Post-shunt hemodynamic support included norepinephrine (92.9%), dopamine (28.6%) and dobutamine (28.6%). Compared with the transcatheter group, surgical patients experienced significantly longer stays in the cardiac intensive care unit (CICU), (8[7-14] vs. 5[4-9] days, p = 0.005), longer durations of mechanical ventilation (2.5[1.5-10.5] vs. 1.8[1.0-4.3] days), and longer total hospitalizations (31[23-36] vs. 25.5[19-46] days). No intraoperative cardiac arrests occurred. The in-hospital mortality rate was 14.3% (4/28). CONCLUSIONS: Both surgical and transcatheter reverse Potts shunt procedures represent feasible salvage therapies for children with refractory pulmonary hypertension, albeit with considerable perioperative risks. Targeted hemodynamic regulation and rigorous intraoperative emergency management are therefore essential to maintain circulatory stability, prevent pulmonary hypertensive crises, and ensure overall clinical safety.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Perioperative anesthetic management in pediatric patients with medically refractory pulmonary arterial hypertension undergoing surgical or transcatheter potts shunt: a retrospective case series
Date Crossref
16/06/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Shanghai Children's Medical Center pays non établi dans la notice
    Établissement de santé
  • Shanghai Jiao Tong University Department of Anesthesiology pays non établi dans la notice
    Université ou école supérieure
  • Shanghai Jiaotong University School of Medicine Shanghai Institute of Pediatric Congenital Heart Disease pays non établi dans la notice
    Université ou école supérieure

Shanghai Children's Medical Center, Department of Anesthesiology — Shanghai Jiao Tong University et Shanghai Institute of Pediatric Congenital Heart Disease — Shanghai Jiaotong University School of Medicine.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pulmonary Hypertension Research and TreatmentsVascular Anomalies and TreatmentsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.